Reverse Total Shoulder Arthroplasty: A Data Analysis on Patients Undergoing Reverse Total Shoulder Arthroplasty
rTSA
1 other identifier
observational
150
1 country
1
Brief Summary
The purpose of this study is to evaluate reverse total shoulder arthroplasty patients preoperative objective measurements and operative objective measurements to determine if there is any effect to postoperative outcomes. Patients who were 18 years old or greater at the time of surgery were followed clinically and radiographically to determine best practice and optimal treatment and technique, risk and rate of complication, and postoperative outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2017
CompletedFirst Submitted
Initial submission to the registry
July 24, 2018
CompletedFirst Posted
Study publicly available on registry
August 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedOctober 25, 2019
October 1, 2019
2 years
July 24, 2018
October 23, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
total operative time
minutes
preoperative to up to 8 years postoperative
amount of blood loss
mls
preoperative to up to 8 years postoperative
Secondary Outcomes (2)
Patient Outcomes
preoperative to up to 8 years postoperative
Patient Outcomes
preoperative to up to 8 years postoperative
Interventions
reverse total shoulder arthroplasty
Eligibility Criteria
All eligible patients of principal investigator receiving rTSA for any indication at St. Elizabeth Healthcare between January 1, 2010 and October 31, 2017 will be evaluated and included in the data analysis.
You may qualify if:
- English speaking
- \>18 years of age
- Reverse TSA performed by principal investigator
You may not qualify if:
- Non-English speaking
- \<18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Orthopaedic Research & Innovation Foundation
Edgewood, Kentucky, 41017, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
R M Greiwe, MD
The Orthopaedic Research & Innovation Foundation
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2018
First Posted
August 6, 2018
Study Start
December 15, 2017
Primary Completion
December 31, 2019
Study Completion
December 31, 2020
Last Updated
October 25, 2019
Record last verified: 2019-10